methotrexate has been researched along with Ankylosing Spondylarthritis in 149 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (6.71) | 18.7374 |
| 1990's | 9 (6.04) | 18.2507 |
| 2000's | 60 (40.27) | 29.6817 |
| 2010's | 55 (36.91) | 24.3611 |
| 2020's | 15 (10.07) | 2.80 |
| Authors | Studies |
|---|---|
| Chhabra, M; Kumar, S; Rashid, M; Venkataraman, R; Zuber, M | 1 |
| Abba, A; Ali, H; Diaby, LM; Niasse, M | 1 |
| Chakravarty, SD; Deodhar, A; Hsia, EC; Husni, ME; Kavanaugh, A; Leu, JH; Lo, KH; Schwartzman, S; Zhou, Y | 1 |
| Baraliakos, X; Bessette, L; de Vlam, K; Deodhar, A; Feng, D; Gao, T; Kato, K; Lippe, R; Maniccia, A; McInnes, IB; Mease, PJ; Ostor, AJK; Saffore, C; Song, IH; Tillett, W; Zueger, P | 1 |
| Charles-Schoeman, C; Choy, E; Curtis, JR; Khan, N; Lippe, R; McInnes, IB; Mysler, E; Nash, P; Palac, H; Shmagel, AK; Suboticki, J; Yamaoka, K | 1 |
| Baker, JF; George, MD; Ogdie, A | 1 |
| Chu, AD; Deodhar, A; Everding, A; Kim, TH; Kishimoto, M; Maksymowych, WP; Pangan, AL; Sieper, J; Song, IH; Sui, Y; van den Bosch, F; van der Heijde, D; Wang, X | 1 |
| Li, F; Li, J; Shi, L; Shu, J; Sun, X; Tang, J | 1 |
| Esterberg, E; Hagimori, K; Nakajo, K; Parikh, RC; Sato, M; Tomita, T | 1 |
| Acer, E; Kaya Erdogan, H; Korkmaz, C; Saracoglu, ZN; Yılmaz, E; Yuksel Canakci, N | 1 |
| Blanco-Madrigal, JM; Bohorquez, C; Caño, R; Castro-Villegas, MC; Díaz-González, F; Díaz-Torné, C; Freire, M; Gómez, S; Gómez-Reino, JJ; Mateo, L; Perez-Garcia, C; Ros-Vilamajo, I; Sánchez-Alonso, F; Sanchez-Piedra, C; Vela, P | 1 |
| Chen, B; Li, L; Wang, G; Zhao, H | 1 |
| Antonisamy, B; Danda, D; Ganapati, A; Gowri, M | 1 |
| Asikainen, J; Borodina, J; Eklund, KK; Ekman, P; Elfving, P; Hiltunen, J; Isomäki, P; Jokiranta, TS; Kaipiainen-Seppänen, O; Kauppi, MJ; Kautiainen, H; Kortelainen, S; Lamberg, T; Leirisalo-Repo, M; Paalanen, K; Parmanne, P; Peltomaa, R; Pirilä, L; Rantalaiho, V; Relas, H; Romu, M; Santisteban, A; Sokka, T; Tadesse, K; Taimen, K; Tuompo, R; Uutela, T; Valleala, H; Vidqvist, KL; Yli-Kerttula, T | 1 |
| Danda, D; Nair, AM; Sandhya, P; Yadav, B | 1 |
| Alegretti, JS; Campos, APB; Maestri, V; Messias-Reason, I; Nisihara, R; Skare, T | 1 |
| Agewall, S; Deyab, G; Hjeltnes, G; Hokstad, I; Hollan, I; Lyberg, T; Mikkelsen, K; Ronda, N; Smastuen, MC; Whist, JE | 1 |
| Aaseth, J; Agewall, S; Deyab, G; Hjeltnes, G; Hokstad, I; Hollan, I; Lyberg, T; Småstuen, MC; Tveiten, D; Whist, JE; Zibara, K | 1 |
| Fernandez, AP; Hu, JZ; Husni, ME; Mazloom, SE; Warren, CB; Ya, J; Yan, D | 1 |
| Bonfa, E; Goldenstein-Schainberg, C; Gonçalves, CR; Moraes, JCB; Ribeiro, ACM; Saad, CGS; Sampaio-Barros, PD; Shimabuco, AY; Waisberg, MG | 1 |
| Al-Mufleh, M; Atelj, A; Prepolec, J; Skuhala, T; Stanimirović, A; Vukelić, D | 1 |
| Nagasaka, K; Niwano, T; Tokura, M | 1 |
| Chen, J; Lin, J; Liu, C; Veras, MM | 1 |
| Das, SK; Dhakad, U | 1 |
| Kay, J; Smolen, JS | 1 |
| Barton, A; Chinoy, H; Griffiths, CE; Jani, M; Warren, RB | 1 |
| da Silva, JA; Duarte, C; Malcata, A; Rovisco, J; Santiago, MG; Santiago, T | 1 |
| Bremell, T; Forsblad-d'Elia, H; Geijer, M; Mörck, B; Pullerits, R | 1 |
| Dreyer, L; Locht, H; Magyari, M; Theibich, A | 1 |
| Braun, J; Fleischmann, R; Goldstein, N; Hsia, EC; Hsu, B; Kavanaugh, A; Kay, J; Keystone, E; Mack, M | 1 |
| Ju, JH; Kwok, SK; Park, KS; Park, SH; Suh, YS; Yoon, CH | 1 |
| Dong, X; Liu, W; Lv, Q; Yang, Z; Zhao, W | 1 |
| Askling, J; Backlin, C; Baecklund, E; Eriksson, JK; Feltelius, N; Hellgren, K; Smedby, KE; Sundstrom, C | 1 |
| Kautiainen, H; Leirisalo-Repo, M; Puolakka, K; Relas, H; Virta, LJ | 1 |
| Choi, YH; Chung, WT; Lee, SH; Lee, SW; Lee, SY; Park, SH; Son, MK; Yoo, YH | 1 |
| Dong, X; Liu, HY; Shi, TY; Zheng, Y | 1 |
| Finzel, K; Godhwani, S; Gruber, BL | 1 |
| Askling, J; Forsblad-d'Elia, H; Jacobsson, LT; Kristensen, LE; Lie, E; Zverkova-Sandström, T | 1 |
| Landewé, RB | 1 |
| Rosenbaum, JT | 1 |
| Kang, JH; Kim, JE; Kim, TJ; Lee, JW; Lee, KE; Lee, SS; Park, DJ; Park, YW; Wen, L; Yim, YR | 1 |
| Chroni, A; Drosos, AA; Gkolfinopoulou, C; Kardassis, D; Stratikos, E; Theofilatos, D; Voulgari, PV | 1 |
| Batteux, B; Boyard, PL; Devauchelle, A; Fardellone, P; Goëb, V; Sejourné, A | 1 |
| Mease, PJ | 1 |
| Braun, J; Fleischmann, R; Goldstein, N; Hsia, EC; Hsu, B; Kay, J; Keystone, E; Zhou, Y | 1 |
| Baccard-Longère, M; Dos Santos, O; Epaulard, O; Germi, R; Lupo, J; Morand, P; Stahl, JP | 1 |
| Agewall, S; Bottazzi, B; Deyab, G; Hjeltnes, G; Hokstad, I; Hollan, I; Leone, R; Lyberg, T; Meroni, PL; Småstuen, MC; Whist, JE | 1 |
| Griffith, JF; Lee, KK; Lee, VW; Li, EK; Li, TK; Tam, LS; Wang, YX | 1 |
| Prati, C; Streit, G; Toussirot, E; Wendling, D | 1 |
| Hutas, G | 1 |
| Argyropoulou, MI; Drosos, AA; Kosta, P; Stergiouli, I; Tsifetaki, N; Voulgari, PV | 1 |
| Amorós, C; Añón, R; Balza, N; Benages, A; Boscá, MM; Corts, JR; Mayordomo, E; Villagrasa, R | 1 |
| Aktekin, LA; Başkan, BM; Bodur, H; Doğan, YP; Ozoran, K; Sivas, F | 1 |
| Baraliakos, X; Braun, J | 1 |
| Oldfield, V; Plosker, GL | 1 |
| Goh, L; Samanta, A | 1 |
| Argin, M; Gumusdis, G; Kabasakal, Y; Kitapcioglu, G; Taylan, A; Yargucu, F | 1 |
| de Vlam, K; Lories, RJ; Van Tilt, I; Westhovens, R | 1 |
| Bathon, JM; Hanicq, D; Kirkpatrick, P; Pappas, DA; Yasothan, U | 1 |
| Egsmose, C; Madsen, OR | 1 |
| Aranda Torres, A; Blanco Pérez, JJ; Guerra Vales, JL; Núñez Delgado, M; Pego Reigosa, JM; Temes Montes, E | 1 |
| Chang, YJ; Chen, LA; Hsu, YL; Su, LH; Tsai, TH | 1 |
| Hong, YS; Ju, JH; Kang, KY; Kim, HY; Kwok, SK; Lee, KY; Park, KS; Park, SH | 1 |
| Ferraro, SM; Giacomelli, L; Marioni, G; Punzi, L; Ramonda, R; Savastano, M | 1 |
| Boyce, EG; Halilovic, J; Stan-Ugbene, O | 1 |
| Bandelow, N; Hasler, P; Wiederkehr, M | 1 |
| Lian, F; Liang, L; Qiu, Q; Xu, H; Yang, X; Ye, Y; Zhan, Z | 1 |
| Danda, D; Gattani, A; Mathew, J; Sandhya, P | 1 |
| Baksay, B; Dér, A; Kovács, A; Szántó, S; Szekanecz, Z | 1 |
| Moghimi, J; Semnani, V; Sheikhvatan, M | 1 |
| Chen, W; Li, JP; Lian, F; Meng, QF; Wang, Y; Yang, JY; Yang, NS; Yang, XY | 1 |
| Ben Amor, N; Bouaziz, A; Zidi, I | 1 |
| Ducourau, E; Goupille, P; Lauféron, F; Mulleman, D; Paintaud, G; Ternant, D; Wendling, D | 1 |
| Ducourau, E; Goupille, P; Lauféron, F; Mulleman, D; Paintaud, G; Ternant, D; Vignault, C; Wendling, D | 1 |
| Darrieux, L; Martin, A; Safa, G | 1 |
| Colebatch, AN; Edwards, CJ; Marks, JL | 1 |
| Azevedo, VF; Fernandes, M; Ferreira, A; Ferreira, AM; Paiva, E; Tosin, T | 1 |
| Bardelli, M; Garcia-Gonzalez, E; Guidelli, GM; Maggio, R | 1 |
| Balblanc, JC; Bossert, M; Lohse-Walliser, A; Verhoeven, F | 1 |
| Xu, L | 1 |
| Divala, T; Rylance, J | 1 |
| Charles, PJ; Midwood, KS; Nicolaidou, V; Page, TH; Piccinini, AM; Taylor, PC | 1 |
| Atagündüz, P; Aydın, SZ; Can, M; Direskeneli, H; Niğdelioğlu, A | 1 |
| Kuzis, S; Ward, MM | 1 |
| De Dios, JR; Queiro, R | 1 |
| Bintley-Bagot, S; Bulgen, DY; Moots, RJ; Roychowdhury, B; Thompson, RN; Tunn, EJ | 1 |
| Toussirot, E; Wendling, D | 3 |
| Jacobsson, L; Mandl, T | 1 |
| De Keyser, F; De Rycke, L; Hoffman, IE; Kruithof, E; Van Damme, N; Van den Bosch, F; Van den Bossche, N; Veys, EM | 1 |
| Kang, XT; Li, XH; Xie, RL | 1 |
| Bresnihan, B; FitzGerald, O; Frosch, M; Kane, D; Roth, J; Vogl, T | 1 |
| Gause, A; Schnabel, A | 1 |
| Chen, J; Liu, C | 1 |
| Gamez-Nava, JI; Garcia-Gonzalez, A; Gonzalez-Lopez, L; Muñoz-Valle, JF; Vazquez-Del-Mercado, M | 1 |
| Bienvenu, J; Coury, F; Fabien, N; Ferraro-Peyret, C; Tebib, JG | 1 |
| El Maghraoui, A | 1 |
| Scott, DL | 1 |
| Conaghan, PG; Emery, P; Greenstein, A; Haugeberg, G; Hensor, E; Jarrett, S; Marzo-Ortega, H; McGonagle, D; O'connor, P; Tan, AL | 1 |
| Komiya, S | 1 |
| Afeltra, A; Amoroso, A; Caricato, M; Coppola, R; Gentilucci, UV; Picardi, A; Rabitti, C; Vadacca, M; Valeri, S; Zardi, EM | 1 |
| Ayhan-Ardic, FF; Gokharman, FD; Oken, O; Ustun, N; Yorgancioglu, ZR | 1 |
| Bisbe, E; Castillo, J; García-Erce, JA; Pérez, C; Sáez, M | 1 |
| Jia, J; Li, J; Wang, Q; Zhang, T | 1 |
| Brandt, A; Brandt, HC; Haibel, H; Listing, J; Rudwaleit, M; Sieper, J; Song, IH | 1 |
| Chou, CT; Chou, MC; Huang, YC; Jan, MS; Lee, HS; Tsay, G; Tsou, HK; Wei, JC; Yang, CC; Yu, CT | 1 |
| Burmester, GR; Scherer, HU | 1 |
| Chen, J; Lin, J; Liu, C | 1 |
| Braun, J; Sieper, J | 1 |
| Heggeness, MH; Lidsky, MD; Reitman, CA | 1 |
| Aboín González, S; Barchino Ortiz, L; Díaz Ley, B; García Acebes, CR; Ruiz Fernández, P; Sánchez de Paz, F | 1 |
| Manger, B; Michels, H; Nüsslein, HG; Schneider, M; Sieper, J | 1 |
| Allard, A; Bachelez, H; Dauendorffer, JN; Rivet, J | 1 |
| Castro, Mdel C; Collantes-Estevez, E; Cravo, AR; Font, P; Muñoz-Gomariz, E; Pérez-Guijo, VC | 1 |
| Szekanecz, Z; Tamási, L | 1 |
| Ahmad, I; Garg, S; Kapoor, S; Malaviya, AN; Raja, RR | 1 |
| Bude, S; Shandwick, W | 1 |
| Chakravarty, A; Chogle, AR; Mishra, H | 1 |
| Goodemote, P; Hoffman, R; Jamieson, B | 1 |
| Baleydier, A; Baron, G; Breban, M; Chary-Valckenaere, I; Claudepierre, P; Combe, B; Dougados, M; Euller-Ziegler, L; Fautrel, B; Fournié, B; Gaudin, P; Henry, YD; Hudry, C; Jousse, S; Le Loët, X; Marcelli, C; Mariette, X; Perdriger, A; Pham, T; Ravaud, P; Solau-Gervais, E; Trape, G; Wendling, D | 1 |
| Heiberg, MS; Kaufmann, C; Koldingsnes, W; Kvien, TK; Mikkelsen, K; Mowinckel, P; Rødevand, E | 1 |
| Akbulut, L; Altay, Z; Ataman, S; Aydoğ, E; Bal, A; Bodur, H; Delialioğlu, SU; Evcik, D; Günaydin, R; Gürsoy, S; Kavuncu, V; Kaya, T; Kocabaş, H; Kotevoğlu, N; Kuran, B; Madenci, E; Olmez, N; Ozel, S; Uğurlu, H; Yazgan, P | 1 |
| Creemers, MC; Franssen, MJ; Gribnau, FW; van de Putte, LB; van Riel, PL | 1 |
| Akama, T; Kashiwagi, H; Natsuda, H; Saito, C; Suzuki, H; Yamane, K; Yuhara, T | 1 |
| Dubost, JJ; Sauvezie, B; Soubrier, M | 1 |
| Sieper, J | 1 |
| Scarpa, R | 1 |
| Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A; Maleknia, T; Pacor, ML | 1 |
| Bertolo, MB; Costallat, LT; Neto, JF; Samara, AM; Sampaio-Barros, PD | 1 |
| Emery, HM | 1 |
| Bodur, H; Borman, P; Güleç, AT; Mocan, G; Seçkin, U; Uçan, H | 1 |
| Barthel, HR | 1 |
| Altan, L; Aydiner, S; Bingöl, U; Karakoç, Y; Yurtkuran, M | 1 |
| Kirwan, JR; Marshall, RW | 1 |
| Blétry, O; De Prost, Y; Frank, R; Godeau, P; Scheuble, C | 1 |
| Miehle, W | 1 |
| Banks, PM; Conn, DL; Witrak, GA | 1 |
| Calin, A; Elswood, J | 1 |
| Atra, E; da Silva, HC; Ferraz, MB | 1 |
| Handler, RP | 1 |
| Richter, MB | 1 |
| Perkins, ES | 1 |
| Missmahl, HP | 2 |
| Deicher, H; Fricke, R; Krull, P | 1 |
| Deicher, H; Fricke, R; Kruli, P | 1 |
34 review(s) available for methotrexate and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Methotrexate related cutaneous adverse drug reactions: a systematic literature review.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Child; Female; Folic Acid; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Spondylitis, Ankylosing; Young Adult | 2022 |
Methotrexate for ankylosing spondylitis.
Topics: Antirheumatic Agents; Humans; Methotrexate; Naproxen; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2013 |
The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Humans; Immunomodulation; Inflammation; Inflammatory Bowel Diseases; Methotrexate; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Receptors, Tumor Necrosis Factor; Risk; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Efficacy evaluation of methotrexate in the treatment of ankylosing spondylitis using meta-analysis.
Topics: Chi-Square Distribution; Humans; Immunosuppressive Agents; Methotrexate; Odds Ratio; Risk Factors; Spondylitis, Ankylosing; Treatment Outcome | 2014 |
Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Comorbidity; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Spondylarthropathies; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Uveitis | 2015 |
Treatment of ankylosing spondylitis and other spondyloarthritides.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Disease Progression; Humans; Immunologic Factors; Methotrexate; Osteogenesis; Spondylarthritis; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2009 |
Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Methotrexate; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2009 |
A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.
Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diphosphonates; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Pamidronate; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Steroids; Sulfasalazine; Tumor Necrosis Factor-alpha | 2009 |
[Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Infliximab; Methotrexate; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2009 |
[Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Arthritis, Rheumatoid; Disease Susceptibility; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Opportunistic Infections; Spondylitis, Ankylosing; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2010 |
New-onset psoriasis associated with etanercept therapy.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Methotrexate; Prednisolone; Psoriasis; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2010 |
Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Topics: Antibodies, Monoclonal; Arthritis, Psoriatic; Arthritis, Rheumatoid; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Humans; Immunologic Factors; Methotrexate; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; United States; United States Food and Drug Administration | 2010 |
Golimumab and immunogenicity? 2010 and beyond.
Topics: Antibodies, Antinuclear; Antibodies, Monoclonal; Antibody Formation; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; DNA; Humans; Immunosuppressive Agents; Methotrexate; Spondylitis, Ankylosing | 2011 |
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Aspirin; Drug Interactions; Drug Therapy, Combination; Humans; Methotrexate; Randomized Controlled Trials as Topic; Spondylarthritis; Spondylitis, Ankylosing | 2011 |
Recent progress in ankylosing spondylitis treatment.
Topics: Celecoxib; Controlled Clinical Trials as Topic; Diphosphonates; Drug Therapy; Humans; Methotrexate; Pamidronate; Pyrazoles; Spondylitis, Ankylosing; Sulfonamides; Tumor Necrosis Factor-alpha | 2003 |
[Rheumatology 2003-part I: research news concerning pathogenesis, epidemiology, diagnosis, and therapy of chronic inflammatory joint diseases].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cells, Cultured; Clinical Trials as Topic; Diagnosis, Differential; Disease Models, Animal; Female; HLA Antigens; Humans; Infliximab; Methotrexate; Middle Aged; Placebos; Polymorphism, Genetic; Pregnancy; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Rats; Spondylarthropathies; Spondylitis, Ankylosing; Time Factors | 2003 |
Methotrexate for ankylosing spondylitis.
Topics: Antirheumatic Agents; Humans; Methotrexate; Naproxen; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2004 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Behcet Syndrome; Diagnosis, Differential; Diphosphonates; Humans; Immunosuppressive Agents; Lung; Methotrexate; Pamidronate; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide; Tomography, X-Ray Computed | 2004 |
Etanercept in arthritis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Etanercept; Humans; Immunoglobulin G; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Treatment Outcome | 2005 |
[Ankylosing spondylitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Blood Sedimentation; Bone Density; Diagnosis, Differential; Etanercept; HLA-B27 Antigen; Humans; Immunoglobulin G; Infliximab; Interleukin-1; Magnetic Resonance Imaging; Methotrexate; Orthopedic Procedures; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Transforming Growth Factor beta | 2005 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Clinical Trials, Phase II as Topic; Cohort Studies; Collagen Diseases; Drug Therapy, Combination; Etanercept; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunoglobulin G; Infliximab; Methotrexate; Placebos; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Remission Induction; Rheumatic Diseases; Rituximab; Spondylarthropathies; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Methotrexate for ankylosing spondylitis.
Topics: Antirheumatic Agents; Humans; Methotrexate; Naproxen; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2006 |
[Mycobacterium marinum infection. Case report and review of the literature].
Topics: Aged; Anti-Bacterial Agents; Azathioprine; Doxycycline; Foot Injuries; Foot Ulcer; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Ulcer; Male; Methotrexate; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Seawater; Spondylitis, Ankylosing; Wound Infection | 2006 |
[Biological therapy of arthritis and systemic autoimmune diseases].
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; B-Lymphocytes; Biological Therapy; Dermatomyositis; Humans; Lupus Erythematosus, Systemic; Methotrexate; Polymyositis; Scleroderma, Systemic; Sjogren's Syndrome; Spondylitis, Ankylosing; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2007 |
[Use of methotrexate in spondylarthropathies. Review of the literature].
Topics: Antimetabolites; Folic Acid Antagonists; Humans; Joint Diseases; Methotrexate; Spondylitis; Spondylitis, Ankylosing | 1996 |
[Treatment of refractory spondylarthropathies].
Topics: Acquired Immunodeficiency Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Humans; Methotrexate; Methylprednisolone; Recurrence; Spondylitis, Ankylosing; Sulfasalazine | 1998 |
Psoriatic arthritis. Is something changing?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Cyclosporine; Gold; Humans; Methotrexate; Spondylitis, Ankylosing; Sulfasalazine | 1999 |
Juvenile rheumatoid arthritis and the spondyloarthropathies.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Diagnosis, Differential; Humans; Methotrexate; Prognosis; Spondylitis, Ankylosing | 1998 |
Therapeutic advances in ankylosing spondylitis.
Topics: Cyclooxygenase Inhibitors; Diphosphonates; Humans; Methotrexate; Pamidronate; Spondylitis, Ankylosing; Thalidomide; Tumor Necrosis Factor-alpha | 2001 |
[Psoriatic arthritis].
Topics: Adult; Amyloidosis; Anthracenes; Arthritis; Arthritis, Reactive; Diagnosis, Differential; Exercise Therapy; Female; HLA Antigens; Humans; Hydrotherapy; Male; Metacarpus; Methotrexate; Myositis; Nails; Psoriasis; Spine; Spondylitis, Ankylosing; Synovitis | 1977 |
Recent advances in the study of uveitis.
Topics: Adult; Antibodies; Antigen-Antibody Reactions; Aqueous Humor; Azathioprine; Cell Migration Inhibition; Chlorambucil; Cyclophosphamide; Female; Histocompatibility Antigens; Humans; Immunity, Cellular; Intraocular Pressure; Lectins; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Prostaglandins; Spondylitis, Ankylosing; Syphilis; Uveitis; Virus Diseases | 1974 |
[Amyloidosis in chronic rheumatic diseases].
Topics: Adult; Aged; Amyloidosis; Arthritis, Rheumatoid; Biopsy; Chloroquine; Chronic Disease; Collagen Diseases; Felty Syndrome; Female; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Proteinuria; Psoriasis; Rectum; Rheumatic Diseases; Sjogren's Syndrome; Spondylitis, Ankylosing | 1968 |
[Treatment of chronic diseases of connective tissue by cytostatic drugs].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
24 trial(s) available for methotrexate and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.
Topics: Arthritis, Psoriatic; Double-Blind Method; Heterocyclic Compounds, 3-Ring; Humans; Methotrexate; Pain; Spondylitis, Ankylosing | 2022 |
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Topics: Adult; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; Humans; Hydroxychloroquine; Janus Kinase Inhibitors; Magnetic Resonance Imaging; Male; Mesalamine; Methotrexate; Middle Aged; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2019 |
Bone changes and curative effect of infliximab in patients with ankylosing spondylitis.
Topics: Adult; Antirheumatic Agents; Biomarkers; Bone and Bones; Female; Humans; Infliximab; Interleukin-33; Male; Methotrexate; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Treatment Outcome | 2015 |
Synoviocyte apoptosis may differentiate responder and non-responder patients to methotrexate treatment in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Apoptosis; Arthritis, Rheumatoid; Case-Control Studies; Cell Cycle; Cell Survival; Cells, Cultured; Female; Humans; In Vitro Techniques; Male; Methotrexate; Middle Aged; Osteoarthritis; Spondylitis, Ankylosing; Synovial Membrane; Time Factors; Young Adult | 2014 |
Effects of tumor necrosis factor-alpha on sexual activity of male patients with ankylosing spondylitis.
Topics: Adult; Antirheumatic Agents; Blood Sedimentation; C-Reactive Protein; Etanercept; Humans; Infliximab; Male; Methotrexate; Middle Aged; Quality of Life; Sexual Behavior; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Image Interpretation, Computer-Assisted; Infliximab; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome | 2008 |
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study.
Topics: Adult; Antibodies; Antibodies, Monoclonal; Antirheumatic Agents; Area Under Curve; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prospective Studies; Spondylitis, Ankylosing; Treatment Outcome | 2011 |
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Drug Interactions; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Models, Theoretical; Prospective Studies; Spondylitis, Ankylosing; Treatment Outcome | 2012 |
Medication toxicity among patients with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Female; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Patient Dropouts; Prospective Studies; Spondylitis, Ankylosing; Sulfasalazine | 2002 |
Is methotrexate effective in ankylosing spondylitis?
Topics: Administration, Oral; Adolescent; Adult; Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Probability; Reference Values; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome; United Kingdom | 2002 |
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
Topics: Adult; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; DNA; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Indirect; Humans; Infliximab; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing | 2003 |
[Methotrexate in conjunction with meloxicam for treating ankylosing spondylitis: a clinical observation of the efficacy and safety].
Topics: Adult; Drug Therapy, Combination; Humans; Male; Meloxicam; Methotrexate; Prospective Studies; Spondylitis, Ankylosing; Thiazines; Thiazoles | 2003 |
Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
Topics: Adult; Antirheumatic Agents; Double-Blind Method; Female; Health Status; Humans; Male; Methotrexate; Middle Aged; Severity of Illness Index; Spondylitis, Ankylosing; Surveys and Questionnaires; Treatment Outcome | 2004 |
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.
Topics: Absorptiometry, Photon; Adult; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antirheumatic Agents; Bone Density; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infliximab; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Sacroiliac Joint; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Treatment of ankylosing spondylitis with medicated moxibustion plus salicylazosulfapyridine and methotrexate--a report of 30 cases.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Moxibustion; Spondylitis, Ankylosing; Sulfasalazine | 2006 |
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial.
Topics: Adult; Antirheumatic Agents; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Patient Dropouts; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Failure | 2007 |
Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prospective Studies; Spondylitis, Ankylosing; Treatment Outcome | 2007 |
A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
Topics: Adolescent; Adult; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonates; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Pamidronate; Spondylitis, Ankylosing; Sulfasalazine | 2007 |
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Spondylitis, Ankylosing; Treatment Outcome | 2008 |
Methotrexate in severe ankylosing spondylitis: an open study.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Female; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 1995 |
Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Aspartate Aminotransferases; C-Reactive Protein; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Indomethacin; Male; Methotrexate; Middle Aged; Pain Measurement; Safety; Spondylitis, Ankylosing; Sulfasalazine | 2000 |
Methotrexate in the treatment of ankylosing spondylitis.
Topics: Adult; Alkaline Phosphatase; Antirheumatic Agents; Aspartate Aminotransferases; Blood Sedimentation; Dyspepsia; Humans; Injections, Intramuscular; Male; Methotrexate; Prospective Studies; Spondylitis, Ankylosing; Syndrome; Treatment Outcome | 2000 |
Clinical investigation of methotrexate in the treatment of ankylosing spondylitis.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Naproxen; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome | 2001 |
91 other study(ies) available for methotrexate and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
[Ankylosing spondylitis in Senegal: epidemiological, diagnostic, therapeutic and evolutionary features at the Hospital Center University Aristide Le Dantec, Dakar].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biological Therapy; Cross-Sectional Studies; Disease Progression; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Retrospective Studies; Senegal; Spondylitis, Ankylosing; Young Adult | 2021 |
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Topics: Administration, Intravenous; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Male; Methotrexate; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Treatment Outcome | 2022 |
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Topics: Adalimumab; Arthritis, Psoriatic; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Methotrexate; Spondylitis, Ankylosing; Venous Thromboembolism | 2023 |
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Methotrexate; Retrospective Studies; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2020 |
Serum homocysteine levels and their association with clinical characteristics of inflammatory arthritis.
Topics: Arthritis, Rheumatoid; Folic Acid; Homocysteine; Humans; Methotrexate; Spondylitis, Ankylosing | 2020 |
Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: A hospital claims database analysis.
Topics: Adalimumab; Adult; Antirheumatic Agents; Facilities and Services Utilization; Female; Health Care Costs; Hospitals; Humans; Infliximab; Japan; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing | 2021 |
Successful treatment of pemphigus foliaceous and ankylosing spondylitis with infliximab and methotrexate: A case report.
Topics: Antirheumatic Agents; Humans; Infliximab; Methotrexate; Pemphigus; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biological Products; Female; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Young Adult | 2020 |
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
Topics: Antirheumatic Agents; Cohort Studies; Humans; Methotrexate; Prospective Studies; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2021 |
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cross-Sectional Studies; Humans; Methotrexate; Spondylarthritis; Spondylitis, Ankylosing; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2022 |
TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis.
Topics: Adult; Cost Savings; Electronic Health Records; Female; Follow-Up Studies; Health Care Costs; Humans; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Mannose-binding lectin (MBL) deficiency and tuberculosis infection in patients with ankylosing spondylitis.
Topics: Adult; Aged; Antirheumatic Agents; Female; Humans; Male; Mannose-Binding Lectin; Metabolism, Inborn Errors; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Tuberculosis; Young Adult | 2018 |
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hyperemia; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2017 |
Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Female; Humans; Male; Methotrexate; Middle Aged; Selenium; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Young Adult | 2018 |
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors.
Topics: Adalimumab; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; C-Reactive Protein; Drug Substitution; Drug Therapy, Combination; Etanercept; Female; Humans; Infliximab; Longitudinal Studies; Male; Methotrexate; Non-Smokers; Prednisone; Remission Induction; Spondylitis, Ankylosing; Time Factors; Tumor Necrosis Factor-alpha | 2018 |
A case report of severe recurrent varicella in an ankylosing spondylitis patient treated with adalimumab - a new side effect after 15 years of usage.
Topics: Acyclovir; Adalimumab; Adult; Anti-Inflammatory Agents; Chickenpox; Herpesvirus 3, Human; Humans; Male; Methotrexate; Pneumonia; Spondylitis, Ankylosing | 2019 |
Successful Treatment of Recurrent Sensorineural Hearing Loss in Ankylosing Spondylitis Using Infliximab and Methotrexate.
Topics: Antirheumatic Agents; Hearing Loss, Sensorineural; Humans; Infliximab; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Andersson lesion in ankylosing spondylitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Back Pain; Bed Rest; Biopsy; Diagnosis, Differential; Folic Acid; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Middle Aged; Spondylitis, Ankylosing; Steroids; Sulfasalazine | 2013 |
Biosimilars to treat inflammatory arthritis: the challenge of proving identity.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Spondylitis, Ankylosing | 2013 |
Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HLA-B27 Antigen; Humans; Inflammation; Infliximab; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Quality of Life; Sacroiliac Joint; Spondylitis, Ankylosing; Time Factors | 2013 |
Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cohort Studies; Demyelinating Diseases; Etanercept; Female; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate; Middle Aged; Nervous System Diseases; Outpatients; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Enzyme Inhibitors; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interferon-gamma Release Tests; Male; Methotrexate; Middle Aged; Mycobacterium tuberculosis; Receptors, Tumor Necrosis Factor; Retrospective Studies; Spondylitis, Ankylosing; Tuberculin Test; Tuberculosis; Tumor Necrosis Factor-alpha | 2014 |
Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Psoriatic; Case-Control Studies; Cohort Studies; Female; Humans; Incidence; Lymphoma; Male; Methotrexate; Middle Aged; Prospective Studies; Registries; Regression Analysis; Retrospective Studies; Risk Factors; Spondylitis, Ankylosing; Sulfasalazine; Sweden; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study.
Topics: Adult; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Female; Finland; Humans; Hydroxychloroquine; Immunoglobulin G; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Registries; Retreatment; Spondylitis, Ankylosing; Treatment Failure; Treatment Outcome | 2014 |
A case of rheumatoid arthritis with Felty syndrome complicated by late-onset ankylosing spondylitis and psoriatic arthritis: a potpourri of rheumatic diseases.
Topics: Adalimumab; Aged; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Felty Syndrome; Humans; Male; Methotrexate; Spondylitis, Ankylosing; Treatment Outcome | 2015 |
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Receptors, Tumor Necrosis Factor; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Conventional DMARDs in axial spondyloarthritis: wishful--rather than rational--thinking!
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Humans; Immunoglobulin G; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Sulfasalazine | 2015 |
Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; C-Reactive Protein; Cohort Studies; Demography; Etanercept; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Spondylitis, Ankylosing; Survival Rate; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis.
Topics: Adult; Antirheumatic Agents; Aryldialkylphosphatase; Cholesterol; Female; Humans; Infliximab; Lipoproteins, HDL; Male; Methotrexate; Methylprednisolone; Middle Aged; Peroxidase; Spondylitis, Ankylosing | 2015 |
Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Glucocorticoids; Humans; Infliximab; Medication Adherence; Methotrexate; Middle Aged; Retrospective Studies; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2016 |
Do Biologic-treated Psoriatic Arthritis Patients with Spondylitis Respond Differently with or without Concomitant Methotrexate from Patients without Spondylitis?
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Biological Products; Humans; Methotrexate; Spondylitis; Spondylitis, Ankylosing | 2016 |
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Methotrexate; Spondylitis, Ankylosing; Treatment Outcome | 2016 |
Herpes simplex type 2 encephalitis and methotrexate medication: a fortuitous or causative association in a patient with spondyloarthritis?
Topics: Acyclovir; Aged; Antiviral Agents; Contraindications, Drug; Encephalitis, Herpes Simplex; Gene Expression; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Methotrexate; Risk Factors; Spondylitis, Ankylosing | 2017 |
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Female; Humans; Inflammation; Male; Methotrexate; Middle Aged; Serum Amyloid P-Component; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease.
Topics: Acyclovir; Adalimumab; Adult; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Herpes Zoster; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Retrospective Studies; Risk Factors; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Valacyclovir; Valine | 2008 |
Golimumab, a fully human monoclonal antibody against TNFalpha.
Topics: Adult; Animals; Antibodies, Monoclonal; Arthritis, Rheumatoid; Asthma; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2008 |
Ankylosing spondylitis and IgA deficiency.
Topics: Adult; Drug Therapy, Combination; Folic Acid; Humans; IgA Deficiency; Magnetic Resonance Imaging; Male; Methotrexate; Prednisone; Radiography; Spine; Spondylitis, Ankylosing; Synovitis; Treatment Outcome | 2009 |
Methotrexate induced sprue-like syndrome.
Topics: Antirheumatic Agents; Atrophy; Biopsy; Celiac Disease; Duodenum; Endoscopy, Gastrointestinal; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Syndrome | 2008 |
Serum homocysteine level in patients with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Methotrexate; Middle Aged; Severity of Illness Index; Spondylitis, Ankylosing; Sulfasalazine | 2009 |
Golimumab (simponi) for inflammatory arthritis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chemistry, Pharmaceutical; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Methotrexate; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Efficacy of SLZ and MTX (alone or combination) on the treatment of active sacroiliitis in early AS.
Topics: Adult; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Retrospective Studies; Sacroiliac Joint; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2009 |
Unusual cervical spine involvement in psoriatic arthritis: a case series.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Cervical Vertebrae; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Male; Meloxicam; Methotrexate; Middle Aged; Neck Pain; Orthopedic Fixation Devices; Range of Motion, Articular; Spondylarthritis; Spondylitis, Ankylosing; Thiazines; Thiazoles; Tramadol | 2009 |
Golimumab.
Topics: Antibodies, Monoclonal; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Methotrexate; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factors | 2009 |
The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
Topics: Absorptiometry, Photon; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Bone Density; Diphosphonates; Drug Therapy, Combination; Etanercept; Female; Femur; Humans; Immunoglobulin G; Infliximab; Lumbar Vertebrae; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Retrospective Studies; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2011 |
Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cohort Studies; Etanercept; Female; Hearing Loss, Sensorineural; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2010 |
[Mononeuritis multiplex under the TNF-alpha inhibitor infliximab].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Demyelinating Diseases; Humans; Immunoglobulins, Intravenous; Infliximab; Male; Methotrexate; Spondylitis, Ankylosing; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population.
Topics: Adolescent; Adult; Asian People; China; Disability Evaluation; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Female; Hip Joint; Humans; Immunoglobulin G; Immunologic Factors; Male; Methotrexate; Radiography; Receptors, Tumor Necrosis Factor; Recovery of Function; Spondylitis, Ankylosing; Time Factors; Treatment Outcome; Young Adult | 2012 |
Outcome of patients with seronegative spondyloarthritis continuing sulphasalazine and methotrexate after a short course of infliximab therapy--experience from a tertiary care teaching hospital in South India.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Drug Therapy, Combination; Female; Health Status; Hospitals, Teaching; Humans; Infliximab; Male; Methotrexate; Middle Aged; Recovery of Function; Serologic Tests; Severity of Illness Index; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Treatment Outcome; Young Adult | 2011 |
Coexistence of ankylosing spondylitis and rheumatoid arthritis in a female patient.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Methotrexate; Methylprednisolone; Middle Aged; Radiography; Recovery of Function; Spine; Spondylitis, Ankylosing; Treatment Outcome | 2011 |
The use of low-dose etanercept as an alternative therapy for treatment of ankylosing spondylitis: a case series.
Topics: Adult; Antirheumatic Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Iran; Low Back Pain; Male; Methotrexate; Middle Aged; Pain Measurement; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Spondylitis, Ankylosing; Time Factors; Treatment Outcome | 2012 |
[Radiological progression and life quality analysis in ankylosing spondylitis patients using etanercept/methotrexate combination therapy].
Topics: Adolescent; Adult; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Quality of Life; Radiography; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Treatment Outcome; Young Adult | 2011 |
Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Humans; Infliximab; Methotrexate; Psoriasis; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Failure; Ustekinumab | 2011 |
Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Opportunistic Infections; Spondylitis, Ankylosing; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Tuberculosis, Splenic; Tumor Necrosis Factor-alpha | 2011 |
Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biopsy; Blotting, Western; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Leishmania infantum; Leishmaniasis, Mucocutaneous; Male; Methotrexate; Methylprednisolone; Middle Aged; Opportunistic Infections; Spondylitis, Ankylosing; Tomography, X-Ray Computed | 2012 |
Aortitis during etanercept therapy for ankylosing spondylitis: finding the culprit.
Topics: Antirheumatic Agents; Aortitis; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Withholding Treatment | 2012 |
Ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Lymphoma, T-Cell; Methotrexate; Middle Aged; Prednisone; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Vincristine | 2011 |
Case report--progressive immobilising back and joint pain.
Topics: Adult; Ankle Joint; Anti-Inflammatory Agents; Antirheumatic Agents; Back Pain; Hip Joint; Humans; Knee Joint; Male; Methotrexate; Pain; Prednisolone; Radiography; Spine; Spondylitis, Ankylosing; Treatment Outcome | 2011 |
Raised circulating tenascin-C in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biomarkers; Blotting, Western; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infliximab; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Myositis; Sjogren's Syndrome; Spondylitis, Ankylosing; Tenascin; Treatment Outcome; Young Adult | 2012 |
Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
Topics: Adult; Antirheumatic Agents; Biological Products; Biomarkers; Blood Sedimentation; C-Reactive Protein; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Severity of Illness Index; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Successful treatment with low-dose weekly methotrexate in a case of undifferentiated spondyloarthropathy coexisting with cutaneous polyarteritis nodosa.
Topics: Dose-Response Relationship, Drug; Female; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Polyarteritis Nodosa; Skin Diseases; Spondylitis, Ankylosing; Treatment Outcome | 2002 |
[Anti-TNF-alpha treatment--an effective complement in spondyloarthropathy].
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Recurrence; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Arthroscopy; Biomarkers; Blood Sedimentation; C-Reactive Protein; Calgranulin A; Calgranulin B; Enzyme-Linked Immunosorbent Assay; Humans; Immunoenzyme Techniques; Knee Joint; Methotrexate; Radiography; Serum Amyloid A Protein; Severity of Illness Index; Spondylitis, Ankylosing; Synovial Fluid; Synovial Membrane | 2003 |
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Arthritis, Rheumatoid; Autoantigens; Autoimmune Diseases; Autoimmunity; beta 2-Glycoprotein I; DNA; Follow-Up Studies; Glycoproteins; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Infliximab; Methotrexate; Prospective Studies; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2004 |
Retroperitoneal fibrosis and ankylosing spondylitis: which links?
Topics: Aortitis; Colonoscopy; Combined Modality Therapy; Diagnosis, Differential; Disease-Free Survival; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Rectal Neoplasms; Retroperitoneal Fibrosis; Retroperitoneal Neoplasms; Spinal Neoplasms; Spondylitis, Ankylosing; Treatment Outcome | 2005 |
Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms.
Topics: Adult; Aged; Arthritis, Rheumatoid; C-Reactive Protein; Female; Humans; Lung; Male; Methotrexate; Middle Aged; Pain Measurement; Pulmonary Fibrosis; Respiratory Function Tests; Smoking; Spondylitis, Ankylosing; Sulfasalazine; Tomography, X-Ray Computed | 2006 |
[Delayed improvement of anemia treated with intravenous iron and epoetin alfa after hip replacement surgery].
Topics: Adult; Anemia, Hypochromic; Arthroplasty, Replacement, Hip; Chronic Disease; Colitis; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Ferric Compounds; Folic Acid; Humans; Intestinal Polyps; Leucovorin; Malabsorption Syndromes; Male; Methotrexate; Osteoarthritis, Hip; Preoperative Care; Recombinant Proteins; Rectal Diseases; Remission Induction; Spondylitis, Ankylosing; Time Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2005 |
Plasma homocysteine status in patients with ankylosing spondylitis.
Topics: Antirheumatic Agents; Case-Control Studies; Cross-Sectional Studies; Drug Therapy, Combination; Homocysteine; Humans; Methotrexate; Spondylitis, Ankylosing; Sulfasalazine | 2007 |
[Spondylarthritides].
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Diagnostic Imaging; Etanercept; Female; HLA-B27 Antigen; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Physical Therapy Modalities; Receptors, Tumor Necrosis Factor; Spine; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine | 2006 |
Neurologic and morphologic features of dural ectasia in ankylosing spondylitis and rheumatoid arthritis: a case report.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Dilatation, Pathologic; Dura Mater; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Radiography; Spinal Cord; Spondylitis, Ankylosing; Treatment Outcome | 2006 |
[Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses].
Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Methotrexate; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2007 |
Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
Topics: Aged; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Humans; Infliximab; Lymphoma, Non-Hodgkin; Male; Methotrexate; Risk Factors; Sezary Syndrome; Skin Neoplasms; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
[Main symptom: chronic deep back pain. Do you know the signs of Bechterew disease?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Humans; Low Back Pain; Methotrexate; Sacroiliac Joint; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Abbott proposes in Europe and the U.S.A. the approval of Humira (adalimumab) for therapy of juvenile idiopathic arthritis. Pediatric clinical trial shows very promising results in juvenile rheumatoid arthritis].
Topics: Adalimumab; Adolescent; Adult; Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Crohn Disease; Drug Therapy, Combination; Europe; Humans; Methotrexate; Placebos; Spondylitis, Ankylosing; Time Factors; United States; United States Food and Drug Administration | 2007 |
A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Diphosphonates; Humans; Methotrexate; Methylprednisolone; Pamidronate; Spondylitis, Ankylosing; Sulfasalazine; Treatment Failure; Tumor Necrosis Factor-alpha | 2007 |
Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Azathioprine; Etretinate; Humans; Infliximab; Joint Diseases; Methotrexate; Nail Diseases; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Longitudinal Studies; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Registries; Rheumatic Diseases; Spondylitis, Ankylosing; Survival Analysis; Tumor Necrosis Factor-alpha | 2008 |
Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Female; Humans; Male; Methotrexate; Middle Aged; Radiography; Rheumatoid Factor; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2008 |
Ankylosing spondylitis successfully treated with methotrexate.
Topics: Adult; Humans; Male; Methotrexate; Psoriasis; Spondylitis, Ankylosing | 1993 |
[Basic therapeutics in the management of various forms of arthritis].
Topics: Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate; Polymyalgia Rheumatica; Remission Induction; Spondylitis; Spondylitis, Ankylosing; Sulfasalazine | 1998 |
Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Dermatitis; Female; Humans; Methotrexate; Prednisolone; Spondylitis, Ankylosing; Vasculitis | 2000 |
Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; HLA-B27 Antigen; Humans; Immunoglobulin G; Indomethacin; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing | 2001 |
Methotrexate in the treatment of ankylosing spondylitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Male; Methotrexate; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Treatment Outcome | 2001 |
[Fiessinger-Leroy-Reiter syndrome with non-obstructive cardiomyopathy treated with methotrexate].
Topics: Arthritis, Reactive; Cardiomyopathies; Electrocardiography; Heart Block; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing | 1979 |
Influence of cytotoxic agents on the development of lymphoid neoplasms in connective tissue diseases.
Topics: Humans; Leukemia, Lymphoid; Lymphoma; Methotrexate; Mixed Connective Tissue Disease; Psoriasis; Spondylitis, Ankylosing | 1979 |
A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cross-Sectional Studies; Diclofenac; Female; Gold; Humans; Ibuprofen; Male; Methotrexate; Middle Aged; Naproxen; Penicillamine; Piroxicam; Prednisolone; Prospective Studies; Spondylitis, Ankylosing; Sulfasalazine; United Kingdom | 1990 |
Low dose methotrexate with leucovorin rescue in AS.
Topics: Adult; Humans; Leucovorin; Male; Methotrexate; Spondylitis, Ankylosing | 1991 |
Favorable results using methotrexate in the treatment of patients with ankylosing spondylitis.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Time Factors | 1989 |
Management of the seronegative spondyloarthropathies.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis; Arthritis, Reactive; Fractures, Spontaneous; Hip Prosthesis; Humans; Methotrexate; Osteotomy; Physical Therapy Modalities; Psoriasis; Spondylitis; Spondylitis, Ankylosing | 1985 |
[Treatment of chronic connective tissue diseases with cytostatics].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Collagen Diseases; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisolone; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
[Amyloidosis in ankylosing spondylitis].
Topics: Amyloidosis; Biopsy; Chloroquine; Diagnosis, Differential; Female; Humans; Kidney Failure, Chronic; Methotrexate; Middle Aged; Prognosis; Proteinuria; Rectum; Spondylitis, Ankylosing | 1969 |